Key facts
- It has raised $750K.
- Notable investors include Antler, Right Side Capital Management, Forum Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Cornucopia Biosciences
- ·The full record, as it builds
Funding rounds
No funding rounds for Cornucopia Biosciences are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cornucopia Biosciences
Provider of high-throughput wet lab and automation services intended to accelerate experimental workflows through integrated planning and execution. The company offers AI-augmented assay support, automated workflow design, laboratory robot integration, and structured experiment reporting, enabling research teams to run validated studies with greater clarity, speed, and reproducibility.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2025
- Employees
- 2
- Website
- cornucopiabio.com/
- Ownership
- Privately Held (backing)
Cornucopia Biosciences doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cornucopia Biosciences shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cornucopia Biosciences in its N-PORT filings yet. We sweep new filings monthly.